Discovery of Natural Xanthines as active molecules in Myotonic Dystrophy models. This is the result of the collaborative project presented at the International Myotonic Dystrophy Conference IDMC-11
IUCT of the InKemia Group, together with the other members of the collaborative project, presented the discovery of the activity of natural Xanthines as active molecules in Myotonic Dystrophy models. These results were presented at the International Myotonic Dystrophy Conference IDMC-11, held in 2017 in San Francisco, USA. These findings were transferred, along with the associated patents, to MyoGem of the InKemia Group for continued development. The interesting results of this project can be seen in the poster presented titled “Natural xanthines rescue myotonic dystrophy-like phenotypes in Drosophila and increase MBNL expression levels”
